EP PerMed: Joint Transnational Call for Proposals 2025 - Horizon Europe

Joint Transnational Call for Proposals (2025) for Pharmacogenomic strategies for personalised medicine approaches (PGxPM2025) Aim of the Call With this call, EP PerMed will fund research projects in human health on pharmacogenomic strategies for PM approaches that address one or more of the following aspects: identification of new pharmacogenomic markers or signatures using (multi)-omics data in relation to drug or drug combination. validation of a pharmacogenomic marker or signatures using (multi)-omics data in predicting drug or drug combination outcomes. use pharmaco-omics strategies to determine the right dosage, the efficacy of treatments and/or the risk of adverse drug response and non-response to treatment to tailor personalised treatment pathways, including combined treatments (multi-medication). Proposals must be interdisciplinary and clearly demonstrate the potential impact on disease outcome and prevention through personalised medicine, as well as the added value of the transnational collaboration; sharing of resources (e.g. registries, diagnoses, biobanks, models, databases, electronic health records, diagnostic and bioinformatics tools), platforms/infrastructures, interoperability of data harmonisation strategies and sharing of specific knowledge important for the project and the PM field (see also section 8 of the “Guidelines for Applicants” on “Scientific Data Open Access Policy”). Eligibility criteria Only transnational projects will be funded. Each consortium...